Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(2)
OTHER(1)
Ftortiazinon (tablets 300 mg) 1/2 dose +placebo+ Maxipim
1 trial
phase_2
gamaleya-research-institute-of-epidemiology-and-microbiology-health-ministry-of-the-russian-federation
Ftortiazinon (tablets 300 mg) full dose + Maxipim
1 trial
phase_2
gamaleya-research-institute-of-epidemiology-and-microbiology-health-ministry-of-the-russian-federation
placebo+Maxipim
1 trial
phase_2
gamaleya-research-institute-of-epidemiology-and-microbiology-health-ministry-of-the-russian-federation
3 unique interventions2 categories

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT03638830Phase 2Completed
Safety and Efficacy Study of Ftortiazinon in the Treatment of Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa
Patients With Complicated Urinary Tract Infections Caused by P. AeruginosaPseudomonas AeruginosaPseudomonas Infections+1 more
PrincipalinvestigatorStart date: 2018-10-17

Research Network

Collaboration Network

14 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa1Pseudomonas aeruginosa1Pseudomonas Infections1Urinary Tract Infections1

Affiliations

St. Petersburg state budgetary institution of health care " city Pokrovskaya hospital"

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Alexander Mangushlo, MD

St. Petersburg state budgetary institution of health care " City hospital № 26"

Moderately Similar
1 trials

Shared therapeutic areas:

Patients With Complicated Urinary Tract Infections Caused by P. AeruginosaPseudomonas aeruginosaPseudomonas Infections+1 more

Worked with same sponsors:

Acellena Contract Drug Research and DevelopmentGamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Collaborated on 1 trial
Similarity Score44%

Ivan Palagin, MD

Smolensk regional clinical hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Patients With Complicated Urinary Tract Infections Caused by P. AeruginosaPseudomonas aeruginosaPseudomonas Infections+1 more

Worked with same sponsors:

Acellena Contract Drug Research and DevelopmentGamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Collaborated on 1 trial
Similarity Score44%

Ashot Yesayan, MD

Saint-Petersburg State Budgetary Healthcare Institution "City Clinical Hospital No. 31"

Moderately Similar
1 trials

Shared therapeutic areas:

Patients With Complicated Urinary Tract Infections Caused by P. AeruginosaPseudomonas aeruginosaPseudomonas Infections+1 more

Worked with same sponsors:

Acellena Contract Drug Research and DevelopmentGamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Collaborated on 1 trial
Similarity Score44%

Alexander Shvets, MD

Saint-Petersburg Clinical Hospital of the Russian Academy of Sciences

Moderately Similar
1 trials

Shared therapeutic areas:

Patients With Complicated Urinary Tract Infections Caused by P. AeruginosaPseudomonas aeruginosaPseudomonas Infections+1 more

Worked with same sponsors:

Acellena Contract Drug Research and DevelopmentGamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Collaborated on 1 trial
Similarity Score44%

Lyudmila Kulagina, MD

Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan

Moderately Similar
1 trials

Shared therapeutic areas:

Patients With Complicated Urinary Tract Infections Caused by P. AeruginosaPseudomonas aeruginosaPseudomonas Infections+1 more

Worked with same sponsors:

Acellena Contract Drug Research and DevelopmentGamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Collaborated on 1 trial
Similarity Score44%

Dmitry Gorelov, MD

Scientific and Research Center "Eco-Safety"

Moderately Similar
1 trials

Shared therapeutic areas:

Patients With Complicated Urinary Tract Infections Caused by P. AeruginosaPseudomonas aeruginosaPseudomonas Infections+1 more

Worked with same sponsors:

Acellena Contract Drug Research and DevelopmentGamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Collaborated on 1 trial
Similarity Score44%

Maria Mozheyko, MD

Yaroslavl Regional Clinical Hospital for Military Veterans

Moderately Similar
1 trials

Shared therapeutic areas:

Patients With Complicated Urinary Tract Infections Caused by P. AeruginosaPseudomonas aeruginosaPseudomonas Infections+1 more

Worked with same sponsors:

Acellena Contract Drug Research and DevelopmentGamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Collaborated on 1 trial
Similarity Score44%

Lev Sinelnikov, MD

S.M. Kirov Military Medical Academy

Moderately Similar
1 trials

Shared therapeutic areas:

Patients With Complicated Urinary Tract Infections Caused by P. AeruginosaPseudomonas aeruginosaPseudomonas Infections+1 more

Worked with same sponsors:

Acellena Contract Drug Research and DevelopmentGamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Collaborated on 1 trial
Similarity Score44%

Igor Shormanov, MD

State Autonomous healthcare institution of Yaroslavl region Clinical hospital № 9

Moderately Similar
1 trials

Shared therapeutic areas:

Patients With Complicated Urinary Tract Infections Caused by P. AeruginosaPseudomonas aeruginosaPseudomonas Infections+1 more

Worked with same sponsors:

Acellena Contract Drug Research and DevelopmentGamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Collaborated on 1 trial
Similarity Score44%

Maksim Bushara, MD

Baltic Medicine

Moderately Similar
1 trials

Shared therapeutic areas:

Patients With Complicated Urinary Tract Infections Caused by P. AeruginosaPseudomonas aeruginosaPseudomonas Infections+1 more

Worked with same sponsors:

Acellena Contract Drug Research and DevelopmentGamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Collaborated on 1 trial
Similarity Score44%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT03638830Phase 2PrincipalInvestigator

Safety and Efficacy Study of Ftortiazinon in the Treatment of Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa

Patients With Complicated Urinary Tract Infections Caused by P. AeruginosaPseudomonas AeruginosaPseudomonas Infections+1 more
Completed

All 1 trials loaded